TABLE 1.
Small molecular agents examined in vitro.
Molecule | Classification | Molecular Weight | Working Concentrations | Cell lineage/Specimen | Delivery Methods | Primary Osteogenic Effect(s) | References |
---|---|---|---|---|---|---|---|
Tivantinib | 3-alkylindoles | 369.4 g/mol | 50 nM, 200 nM | 17IA4 mouse dental pulp cells | Pulp cell culture using standard culture medium treated with tivantinib | Axin2 and Wnt/β-catenin pathway upregulation | Birjandi et al. (2020) |
Tideglusib | Naphthalenes | 334.4 g/mol | 50 nM | Rat dental pulp cells | Pulp cell culture using α-MEM medium treated with tideglusib | Promote odontoblast-like cell differentiation; ALP-positive calcified nodules in isolated rat dental pulp cells | Masuda et al. (2020) |
Purmorphamine | Purine | 520.6 g/mol | 2 μM | Human DPSCs from soft tissue of extracted third molar | β-TCP granules cell-scaffolds cultured in stem cell growth or osteogenic media | Increased ALP activity; OPN , OCN upregulation; stem cell proliferation | Rezia Rad et al. (2016) |
Chemical cocktail* | Assortment (see footnote) | Assortment (see footnote) | Assortment (see footnote) | Human DPSCs from soft tissue of extracted third molars, donated human SCAPs, donated GMSCs | Stem cell culture using standard medium treated with chemical cocktail | NeuN, NFM, NSE, MAP2 expression in DPSCs and SCAPs; Musashi1, βIII-Tubulin, NGN2, MASH1 expression in GMSCs | Heng et al. (2019) |
Dimethyloxalylglycine | Glycine derivative | 175.1 g/mol | 1% w/w of PLGA | Human PDLSCs from periodontal ligament of extracted premolars | Stem cells were inoculation using α-MEM growth medium treated with DMOG | Increased ALP activity; Runx2 , OPN, OCN, BSP expression | Shang et al. (2021) |
Citrate | Tricarboxylic acids | 189.1 g/mol | 200 μM | Human MSCs from bone marrow of healthy, non-diabetic adults | Stem cells treated with an osteogenic medium supplemented with pH-adjusted citrate | Increased ALP activity; OPN, Runx2, Col1a1, SPP1 expression; higher calcium/protein ratios | Ma et al. (2018) |
Fluoride | Halogen | 19 g/mol | Different concentrations between 0 ppm and 200 ppm | Tendons extracted from tails of 12–18 week old Sprague Dawley rats | Rat tendons mineralized in 50 mM Tris buffer with 0, 0.5, 1, 2, | Enhanced crystallization and rod-like mineralization | Saxena et al. (2018) |
SB431542 | Benzamides | 384.4 g/mol | 100 μM | Human iPSC-MSCs yielded from sub-culture of bone marrow hiPSCs in MSC medium | Stem cell culture using standard medium, then osteogenic medium after cells attached to CPC scaffold | Promotes stem cell proliferation, differentiation, and viability | Song et al. (2021) |
. | . | . | 10 μM | Human PObs obtained from child calvarial bone graft patients and mouse PObs harvested from the skulls of mice; Mouse DM cells harvested from dural membrane of mice | Calvarial cell culture using osteogenic differentiation medium treated with SB431542 | Increased BMP signaling; increased OCN and Runx2 expression; reduction in activity of Caspase 3; upregulated Smad6 | Senarath-Yapa et al. (2016) |
Resveratrol | Stilbenes | 228.2 g/mol | 1.0 mg/ml | Mouse MSCs isolated from bone marrow flushes of female FVB mice | Stem cells were inoculated in growth medium with RSV and RSV-SrRn scaffolds | Increased BMP2 signaling; osteoblastic differentiation; Wnt/β-cateninsignaling upregulation; mineralization in mouse MSCs; angiogenesis | Zhang et al. (2020) |
Strontium ranelate | Tetracarboxylic acids | 513.5 g/mol | 1.0 mg/ml | Mouse MSCs isolated from bone marrow flushes of female FVB mice | Stem cells were inoculated in growth medium with SrRn and RSV-SrRn scaffolds | Increased ALP activity; Inhibited degenerative osteoclast activity | Zhang et al. (2020) |
ML323 | - | 384.5 g/mol | 10 μM | Human DPSCs from soft connective tissue of third molars | Stem cells were inoculated in osteogenic differentiation medium treated with ML323 | Increased ALP activity; increased calcium accumulation; enhanced osteodifferentiation | Kim and Choung. (2020) |
6-Bromoindirubin-3'- | Indole derivative | 356.2 g/mol | 200 nM, 400 nM, 800 nM | Human DPSCs from soft connective tissue of third molars Oxime | Stem cells were cultured using DMEM growth medium treated with BIO | Increased of ALP activity; ANKH, ENPP1, RUNX2, OSX, OCN, DSPP, DMP1, and OPG expression; RANKL downregulation; enhanced osteoblastic differentiation and mineralized nodule formation | Chatvadee et al. (2022) |
*Valproic acid (Propylpentanoic acid derivative; 144.2 g/mol; 0.5 mM), Forskolin (Labdane diterpenoids; 410.5 g/mol; 10 μM), SP600125 (Anthrapyrazoles; 220.2 g/mol; 10 μM), GO6983 (Maleimides; 442.5 g/mol; 5 μM), Y-27632 (N-arylamides; 247.3 g/mol; 5 μM), Repsox (Pyrazolopyridine.; 287.3 g/mol; 1 μM), CHIR99021 (Aminopyrimidines; 465.3 g/mol; 3μM), Dorsomorphin (Pyrazolopyridine; 399.5 g/mol; 1 μM).